Health Canada – HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the marketing authorisations for its amyotrophic lateral sclerosis (ALS) therapy after the drug failed in a last-stage trial.

Amylyx Pharma pulls out ALS therapy drug from US, Canada

HQ Team April 4, 2024: Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the.

by HealthQuill
April 4, 2024
0 Comments

Climate Drugs Pharma

Canada invites stakeholders’ response to new pesticide rules

HQ Team July 12, 2023: Canadian government has invited stakeholders’ feedback on proposed amendments to the Pest Control Products Regulations on planned curbs.

by HealthQuill
July 12, 2023
0 Comments

About Us

Contact Info

Follow Us

Amylyx Pharma pulls out ALS therapy drug from US, Canada

Canada invites stakeholders’ response to new pesticide rules